Suppr超能文献

人类冠状病毒的结构蛋白:它们有何不同之处?

Structural proteins of human coronaviruses: what makes them different?

作者信息

Minigulov Nail, Boranbayev Kuandyk, Bekbossynova Ayaulym, Gadilgereyeva Bakhytgul, Filchakova Olena

机构信息

Biology Department, School of Sciences and Humanities, Nazarbayev University, Astana, Kazakhstan.

出版信息

Front Cell Infect Microbiol. 2024 Dec 6;14:1458383. doi: 10.3389/fcimb.2024.1458383. eCollection 2024.

Abstract

Following COVID-19 outbreak with its unprecedented effect on the entire world, the interest to the coronaviruses increased. The causative agent of the COVID-19, severe acute respiratory syndrome coronavirus - 2 (SARS-CoV-2) is one of seven coronaviruses that is pathogenic to humans. Others include SARS-CoV, MERS-CoV, HCoV-HKU1, HCoV-OC43, HCoV-NL63 and HCoV-229E. The viruses differ in their pathogenicity. SARS-CoV, MERS-CoV, and SARS-CoV-2 are capable to spread rapidly and cause epidemic, while HCoV-HKU1, HCoV-OC43, HCoV-NL63 and HCoV-229E cause mild respiratory disease. The difference in the viral behavior is due to structural and functional differences. All seven human coronaviruses possess four structural proteins: spike, envelope, membrane, and nucleocapsid. Spike protein with its receptor binding domain is crucial for the entry to the host cell, where different receptors on the host cell are recruited by different viruses. Envelope protein plays important role in viral assembly, and following cellular entry, contributes to immune response. Membrane protein is an abundant viral protein, contributing to the assembly and pathogenicity of the virus. Nucleocapsid protein encompasses the viral RNA into ribonucleocapsid, playing important role in viral replication. The present review provides detailed summary of structural and functional characteristics of structural proteins from seven human coronaviruses, and could serve as a practical reference when pathogenic human coronaviruses are compared, and novel treatments are proposed.

摘要

在新型冠状病毒肺炎(COVID-19)疫情爆发并对全球产生前所未有的影响之后,人们对冠状病毒的关注度有所增加。COVID-19的病原体严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是七种可致人类致病的冠状病毒之一。其他包括严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)、人冠状病毒HKU1(HCoV-HKU1)、人冠状病毒OC43(HCoV-OC43)、人冠状病毒NL63(HCoV-NL63)和人冠状病毒229E(HCoV-229E)。这些病毒的致病性各不相同。SARS-CoV、MERS-CoV和SARS-CoV-2能够迅速传播并引发疫情,而HCoV-HKU1、HCoV-OC43、HCoV-NL63和HCoV-229E则引起轻度呼吸道疾病。病毒行为的差异归因于结构和功能的不同。所有七种人类冠状病毒都拥有四种结构蛋白:刺突蛋白、包膜蛋白、膜蛋白和核衣壳蛋白。带有受体结合域的刺突蛋白对于进入宿主细胞至关重要,不同的病毒会募集宿主细胞上不同的受体。包膜蛋白在病毒组装中起重要作用,并且在进入细胞后,有助于免疫反应。膜蛋白是一种丰富的病毒蛋白,有助于病毒的组装和致病性。核衣壳蛋白将病毒RNA包裹成核糖核衣壳,在病毒复制中起重要作用。本综述详细总结了七种人类冠状病毒结构蛋白的结构和功能特征,在比较致病性人类冠状病毒和提出新的治疗方法时可作为实用参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3720/11659265/85837073d5f8/fcimb-14-1458383-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验